Trial Outcomes & Findings for Clinical Efficacy Evaluation of Three Dentifrices (NCT NCT03988374)
NCT ID: NCT03988374
Last Updated: 2021-08-23
Results Overview
Mean Within-Treatment Whole-Mouth Score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.
COMPLETED
PHASE2
319 participants
baseline, six weeks, 3 months and 6 months
2021-08-23
Participant Flow
Participant milestones
| Measure |
0% Baking Soda Dentifrice
Dentifrice, not containing baking soda, evaluated for ability to reduce gingivitis and plaque following 6-months of use.
|
20% Baking Soda Dentifrice
Dentifrice, containing 20% baking soda, evaluated for ability to reduce gingivitis and plaque following 6-months of use.
|
35% Baking Soda Dentifrice
Dentifrice, containing 35% baking soda, evaluated for ability to reduce gingivitis and plaque following 6-months of use.
|
|---|---|---|---|
|
Overall Study
STARTED
|
104
|
107
|
108
|
|
Overall Study
COMPLETED
|
103
|
105
|
107
|
|
Overall Study
NOT COMPLETED
|
1
|
2
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
0% Baking Soda Dentifrice
n=103 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
20% Baking Soda Dentifrice
n=105 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
35% Baking Soda Dentifrice
n=107 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
Total
n=315 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
44.07 Age
n=103 Participants
|
47.50 Age
n=105 Participants
|
47.32 Age
n=107 Participants
|
46.3 Age
n=315 Participants
|
|
Sex: Female, Male
Female
|
75 Participants
n=103 Participants
|
74 Participants
n=105 Participants
|
80 Participants
n=107 Participants
|
229 Participants
n=315 Participants
|
|
Sex: Female, Male
Male
|
28 Participants
n=103 Participants
|
31 Participants
n=105 Participants
|
27 Participants
n=107 Participants
|
86 Participants
n=315 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
Canada
|
103 participants
n=103 Participants
|
105 participants
n=105 Participants
|
107 participants
n=107 Participants
|
315 participants
n=315 Participants
|
|
Gingvial Efficacy
|
2.081 units on a scale
n=103 Participants
|
2.094 units on a scale
n=105 Participants
|
2.092 units on a scale
n=107 Participants
|
2.089 units on a scale
n=315 Participants
|
|
Gingival Bleeding Efficacy
|
0.165 units on a scale
n=103 Participants
|
0.178 units on a scale
n=105 Participants
|
0.189 units on a scale
n=107 Participants
|
0.177 units on a scale
n=315 Participants
|
|
Plaque Efficacy
|
2.409 units on a scale
n=103 Participants
|
2.411 units on a scale
n=105 Participants
|
2.356 units on a scale
n=107 Participants
|
2.4 units on a scale
n=315 Participants
|
PRIMARY outcome
Timeframe: baseline, six weeks, 3 months and 6 monthsMean Within-Treatment Whole-Mouth Score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.
Outcome measures
| Measure |
0% Baking Soda Dentifrice
n=103 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
20% Baking Soda Dentifrice
n=105 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
35% Baking Soda Dentifrice
n=107 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
|---|---|---|---|
|
Mean Within-Treatment Whole-Mouth Score - Gingival Efficacy
Baseline
|
2.081 units on a scale
Standard Deviation 0.096
|
2.094 units on a scale
Standard Deviation 0.117
|
2.092 units on a scale
Standard Deviation 0.106
|
|
Mean Within-Treatment Whole-Mouth Score - Gingival Efficacy
6 weeks
|
1.996 units on a scale
Standard Deviation 0.138
|
1.919 units on a scale
Standard Deviation 0.171
|
1.882 units on a scale
Standard Deviation 0.174
|
|
Mean Within-Treatment Whole-Mouth Score - Gingival Efficacy
3 months
|
1.980 units on a scale
Standard Deviation 0.155
|
1.841 units on a scale
Standard Deviation 0.198
|
1.766 units on a scale
Standard Deviation 0.229
|
|
Mean Within-Treatment Whole-Mouth Score - Gingival Efficacy
6 months
|
1.946 units on a scale
Standard Deviation 0.149
|
1.763 units on a scale
Standard Deviation 0.209
|
1.653 units on a scale
Standard Deviation 0.256
|
PRIMARY outcome
Timeframe: baseline, six week, three months, and six monthsMean Within-Treatment Whole-Mouth Score as measured by Gingival Bleeding Index (0=absence of bleeding after 30 seconds, 1= bleeding observed after 30 seconds, 2= bleeding occurs instantly). The scale ranges from 0-2.
Outcome measures
| Measure |
0% Baking Soda Dentifrice
n=103 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
20% Baking Soda Dentifrice
n=105 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
35% Baking Soda Dentifrice
n=107 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
|---|---|---|---|
|
Mean Within-Treatment Whole-Mouth Score - Gingival Bleeding Efficacy
Baseline
|
0.165 units on a scale
Standard Deviation 0.085
|
0.178 units on a scale
Standard Deviation 0.129
|
0.189 units on a scale
Standard Deviation 0.114
|
|
Mean Within-Treatment Whole-Mouth Score - Gingival Bleeding Efficacy
6 weeks
|
0.149 units on a scale
Standard Deviation 0.091
|
0.135 units on a scale
Standard Deviation 0.122
|
0.122 units on a scale
Standard Deviation 0.081
|
|
Mean Within-Treatment Whole-Mouth Score - Gingival Bleeding Efficacy
3 months
|
0.141 units on a scale
Standard Deviation 0.088
|
0.116 units on a scale
Standard Deviation 0.117
|
0.094 units on a scale
Standard Deviation 0.067
|
|
Mean Within-Treatment Whole-Mouth Score - Gingival Bleeding Efficacy
6 months
|
0.129 units on a scale
Standard Deviation 0.082
|
0.096 units on a scale
Standard Deviation 0.104
|
0.069 units on a scale
Standard Deviation 0.053
|
PRIMARY outcome
Timeframe: baseline, six weeks, three months, and six monthsMean Within-Treatment Whole-Mouth Score as measured by Plaque Index (0=no visible plaque, 1=separate flecks of plaque at the cervical margin of the tooth, 2=a thin, continuous band of plaque (up to 1mm wide) at the cervical margin, 3= a band of plaque wider than 1 mm but covering less than one-third of the crown, 4=plaque covering at least one-third but less than two-thirds of the crown, 5= plaque covering two-thirds or more of the crown). The scale ranges from 0-5.
Outcome measures
| Measure |
0% Baking Soda Dentifrice
n=103 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
20% Baking Soda Dentifrice
n=105 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
35% Baking Soda Dentifrice
n=107 Participants
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
|---|---|---|---|
|
Mean Within-Treatment Whole-Mouth Score - Plaque Efficacy
3 months 3 months
|
2.251 units on a scale
Standard Deviation 0.202
|
2.066 units on a scale
Standard Deviation 0.260
|
1.907 units on a scale
Standard Deviation 0.265
|
|
Mean Within-Treatment Whole-Mouth Score - Plaque Efficacy
Baseline
|
2.409 units on a scale
Standard Deviation 0.220
|
2.411 units on a scale
Standard Deviation 0.244
|
2.356 units on a scale
Standard Deviation 0.240
|
|
Mean Within-Treatment Whole-Mouth Score - Plaque Efficacy
6 weeks
|
2.280 units on a scale
Standard Deviation 0.211
|
2.134 units on a scale
Standard Deviation 0.259
|
2.026 units on a scale
Standard Deviation 0.227
|
|
Mean Within-Treatment Whole-Mouth Score - Plaque Efficacy
6 months
|
2.196 units on a scale
Standard Deviation 0.191
|
1.925 units on a scale
Standard Deviation 0.239
|
1.793 units on a scale
Standard Deviation 0.287
|
Adverse Events
0% Baking Soda Dentifrice
20% Baking Soda Dentifrice
35% Baking Soda Dentifrice
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
0% Baking Soda Dentifrice
n=103 participants at risk
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
20% Baking Soda Dentifrice
n=105 participants at risk
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
35% Baking Soda Dentifrice
n=107 participants at risk
Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.
|
|---|---|---|---|
|
General disorders
Primary discomforts
|
0.00%
0/103 • 6 months
|
2.9%
3/105 • Number of events 3 • 6 months
|
1.9%
2/107 • Number of events 2 • 6 months
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee Master service agreement and confidentiality agreement in place
- Publication restrictions are in place
Restriction type: OTHER